FDA cites quality issues at Rentschler and Eli Lilly facilities
A year after the FDA inspected a Rentschler Biopharma manufacturing site in Germany, the agency discovered more issues.
In an inspection that took place in …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
